KP372-1 is primarily utilized in cancer research due to its ability to inhibit key signaling pathways involved in tumor growth and survival. It targets PDK1, Akt, and Flt, which are critical components of cellular processes like proliferation, metabolism, and apoptosis. By blocking these pathways, KP372-1 effectively suppresses the survival of cancer cells, making it a promising candidate for studying novel therapeutic strategies. Its application is particularly relevant in investigating drug resistance mechanisms and developing targeted treatments for cancers that rely on these signaling networks, such as certain types of leukemia and solid tumors. Additionally, it serves as a valuable tool in preclinical studies to understand the molecular basis of cancer progression and to evaluate the efficacy of combination therapies.